Stereotactic Body Radiotherapy For Castration-Sensitive Prostate Cancer Bone Oligometastases

被引：0
|
作者：
Fanetti, G. [1 ]
Marvaso, G. [1 ]
Rese, A. [2 ]
Ricotti, R. [1 ]
Ciardo, D. [1 ]
Rondi, E. [3 ]
Comi, S. [3 ]
Cattani, F. [3 ]
Zerini, D. [1 ]
Fodor, C. [1 ]
De Cobelli, O. [4 ]
Orecchia, R. [5 ]
Jereczek-Fossa, B. [1 ]
机构：
[1] European Inst Oncol, Div Radiat Oncol, Milan, Italy
[2] Federico II Univ Hosp, Div Radiat Oncol, Naples, Italy
[3] European Inst Oncol, Unit Med Phys, Milan, Italy
[4] European Inst Oncol, Div Urol, Milan, Italy
[5] European Inst Oncol, Dept Med Imaging & Radiat Sci, Milan, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)31874-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1565
引用
收藏
页码：S843 / S844
页数：2
相关论文
共 50 条
  • [41] Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer
    Mitchell, Aaron P.
    Nemirovsky, David
    Meza, Akriti Mishra
    Chakraborty, Nirjhar
    Persaud, Sonia
    Farooki, Azeez
    Morris, Michael J.
    JCO ONCOLOGY PRACTICE, 2024, 20 (03) : 393 - 400
  • [42] Stereotactic Body Radiotherapy for Prostate Cancer
    Parikh, Neil R.
    Kishan, Amar U.
    AMERICAN JOURNAL OF MENS HEALTH, 2020, 14 (03)
  • [43] Stereotactic body radiotherapy in bone oligometastatic prostate cancer: a retrospective study
    Trippa, F.
    Costantini, S.
    Terenzi, S.
    Ingrosso, G.
    Scoccianti, S.
    Di Marzo, A.
    Detti, B.
    Triggiani, L.
    Borghesi, S.
    Bardoscia, L.
    Puccini, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1236 - S1236
  • [44] Management of pulmonary oligometastases by stereotactic body radiotherapy
    Gamsiz, Hakan
    Beyzadeoglu, Murat
    Sager, Omer
    Dincoglan, Ferrat
    Demiral, Selcuk
    Uysal, Bora
    Surenkok, Serdar
    Oysul, Kaan
    Dirican, Bahar
    TUMORI, 2014, 100 (02) : 179 - 183
  • [45] Stereotactic Body Radiotherapy for Oligometastases: An Opportunity for Cure?
    Kauffmann, Greg
    Lemons, Jeffrey
    Chmura, Steven J.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (08) : 23 - 26
  • [46] Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
    Miyake, Hideaki
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (03) : 1391 - 1396
  • [47] Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer
    Pasqualetti, Francesco
    Montrone, Sabrina
    Vivaldi, Caterina
    Zani, Margherita
    Fedele, David
    Fornaro, Lorenzo
    Pasqualetti, Giuseppe
    Salvatore, Lisa
    Manfredi, Bruno
    Laliscia, Concetta
    Coraggio, Gabriele
    Gonnelli, Alessandra
    Loupakis, Fotios
    Masi, Gianluca
    Sainato, Aldo
    Monzani, Fabio
    Falcone, Alfredo
    Paiar, Fabiola
    ANTICANCER RESEARCH, 2017, 37 (01) : 315 - 319
  • [48] Re: Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 26 - 28
  • [49] First-line Therapy for Metastatic Castration-sensitive Prostate Cancer
    Lau, Y. H.
    Wan, L. Y.
    Lam, M. H. C.
    HONG KONG JOURNAL OF RADIOLOGY, 2022, 25 (03): : 244 - 245
  • [50] Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer
    Dandapani, Savita V.
    Wong, Jeffrey
    Twardowski, Przemyslaw
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (07) : 490 - 496
12345